Crohn's disease treatment focuses on reducing inflammation, managing symptoms, and preventing complications through a combination of medications, dietary adjustments, and surgery when necessary. While there is no cure, personalised therapies aim to achieve and maintain remission. Below is a detailed breakdown of current approaches:

Medications

Anti-inflammatory drugs

Aminosalicylates (e.g., mesalamine) are used for mild to moderate cases, particularly when the colon is involved.

Corticosteroids (e.g., prednisone, budesonide) provide rapid symptom relief during flare-ups but are limited to short-term use (3–4 months) due to risks like osteoporosis and infections.

Immunomodulators

Azathioprine and methotrexate suppress immune activity to reduce inflammation. These require regular blood monitoring for side effects like liver toxicity.

Biologic therapies

TNF inhibitors (e.g., infliximab, adalimumab) and IL-12/23 inhibitors (e.g., ustekinumab) target specific inflammatory proteins. Biologics are effective for moderate to severe cases unresponsive to other treatments.

Integrin blockers (e.g., vedolizumab) and IL-23 inhibitors (e.g., risankizumab) are newer options with gut-specific action.

JAK inhibitors

Upadacitinib is an oral medication that blocks immune signalling pathways and is used for refractory cases.

Antibiotics

Ciprofloxacin or metronidazole treat abscesses and fistulas, common complications of Crohn’s.

Symptom management

Anti-diarrhoeals (e.g., loperamide) and pain relievers (e.g., acetaminophen) address symptoms but must be used cautiously to avoid worsening strictures or inflammation.

Surgery

About 40–60% of patients require surgery within 10 years of diagnosis, often for strictures, fistulas, or obstructions. Common procedures include:

Bowel resection to remove damaged sections.

Strictureplasty to widen narrowed areas.
Recurrence after surgery occurs in over 50% of patients, necessitating ongoing medical management.

Diet and Lifestyle

While no specific diet cures Crohn’s, temporary adjustments (e.g., low-fibre during flares) can ease symptoms. Nutritional supplements address deficiencies caused by malabsorption.

Major Considerations

Steroid-sparing strategies: Long-term reliance on steroids is discouraged; immunomodulators or biologics are preferred for maintenance.

Personalisation: Treatment plans depend on disease severity, location, and patient response. Biologics and small-molecule drugs (e.g., JAK inhibitors) are prioritised for high-risk cases.

Monitoring: Regular blood tests and imaging track inflammation and medication safety.

Effective management balances rapid symptom control with long-term remission, minimising complications and improving quality of life.

Crohn’s Disease